OpenAI Acquires Biotech Agent Developer to Expand Life Sciences Platform

OpenAI has bought Orchestra Bio, a startup that creates automated software agents for managing clinical trials and pharmaceutical workflows. The acquired technology and personnel will be added to OpenAI's dedicated health research platform, Rosalind.